Nasal Group 2 Innate Lymphoid Cells Accumulate during COX-1 Inhibition in Aspirin- Exacerbated Respiratory Disease

Nasal Group 2 Innate Lymphoid Cells Accumulate during COX-1 Inhibition in Aspirin- Exacerbated Respiratory Disease

Group 2 innate lymphoid cells (ILC2s), which promote tissue eosinophilia and mast cell responses, undergo chemotaxis and cytokine production in response to PGD2 but it is unknown whether ILC2s are active in AERD.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB194-AB194
Hauptverfasser: Eastman, Jacqueline J., MD, Cavagnero, Kellen J., B.S, Deconde, Adam S., MD, Kim, Alexander S., MD, Broide, David H., MB, ChB, FAAAAI, Zuraw, Bruce L., MD, White, Andrew A., MD, FAAAAI, Christiansen, Sandra C., MD, FAAAAI, Doherty, Taylor Alan, MD, FAAAAI
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Respiratory diseases
T cell receptors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Group 2 innate lymphoid cells (ILC2s), which promote tissue eosinophilia and mast cell responses, undergo chemotaxis and cytokine production in response to PGD2 but it is unknown whether ILC2s are active in AERD.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2016.12.631